Mitomycin C bladder instillation therapy for bladder tumors. 1975

T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori

Patients with bladder tumors underwent a course of topical bladder instillation of 20 mg. mitomycin C in 20 ml. sterilized distilled water 3 times weekly for a total of 20 procedures. In 22 of the 50 patients (44 per cent) the tumors disappeared completely, while in 16 patients (32 per cent) there was partial disappearance and in 12 patients (24 per cent) there was no affect. Therefore, the total effective rate was 76 per cent. We concluded from our studies that mitomycin C topical therapy could be applied to low stage and low grade bladder tumors less than 1 cm. in diameter, without regard to the number of tumors. We now use mitomycin C topical therapy in all cases of bladder tumors. Local bladder reaction was noted in 3 cases but a complete course of therapy was accomplished in each case--in 2 cases without interruption of treatment and in 1 case by delaying treatment for 1 week. Abnormal values of hematocrit, white blood cells and platelets in blood were not observed during therapy.

UI MeSH Term Description Entries
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D014555 Urination Disorders Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE. Disorder, Urination,Disorders, Urination,Urination Disorder

Related Publications

T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
January 1987, Cancer chemotherapy and pharmacology,
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
January 1992, Cancer chemotherapy and pharmacology,
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
April 1985, Cancer,
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
April 1979, The Tohoku journal of experimental medicine,
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
March 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
February 1986, Lancet (London, England),
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
January 1986, Lancet (London, England),
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
January 1982, The Tohoku journal of experimental medicine,
T Mishina, and K Oda, and S Murata, and H Ooe, and Y Mori
April 2022, Aktuelle Urologie,
Copied contents to your clipboard!